The largest database of trusted experimental protocols
> Disorders > Sign or Symptom > Hyperoxia

Hyperoxia

Hyperoxia refers to an abnormally high concentration of oxygen in the body's tissues.
This condition can occur during oxygen therapy or in certain medical conditions.
Hyperoxia has been studied for its potential therapeutic applications, particularly in the context of conditions such as stroke, traumatic brain injury, and other ischemic disorders.
However, optimizing hyperoxia protocols can be challenging, as the effects can vary depending on factors like duration, oxygen concentration, and method of delivery.
PubCompare.ai helps users locate protocols from literate, pre-prints, and patents while using AI-driven comparisons to identify the best protocols and products for reproducible, evidence-based hyperoxia research.

Most cited protocols related to «Hyperoxia»

Animals randomized to IH were placed with the dams in specialized oxygen chambers attached to an oxycycler (BioSpherix, New York) as previously described (25 (link),26 (link),27 (link),28 (link),29 (link)). The IH profile consisted of keeping the rat pups in hyperoxia (50%) with intermittent burst of three clustered episodes of hypoxia (12%) each 10 min apart every 3 h as described previously from our laboratory (27 (link),29 (link)). Thus, the neonatal pups were subjected daily to eight of these clustered episodes of intermittent hypoxia during hyperoxia to simulate a preterm newborn having repeated desaturations while on 50% inspired oxygen. This clustering design has been shown to produce a severe form of OIR in neonatal rats (25 (link),26 (link),27 (link),28 (link),29 (link)). Refer to Supplementary Figure S5 online for the intermittent hypoxia profile.
Publication 2016
Animals Hyperoxia Hypoxia Infant, Newborn Oxygen Rattus

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2011
Cells Cytochrome P-450 CYP1A1 DNA, Complementary Enzymes Genes Hyperoxia Oligonucleotide Primers Omeprazole Real-Time Polymerase Chain Reaction RNA, Messenger RNA-Directed DNA Polymerase Sulfoxide, Dimethyl SYBR Green I
The normobaric hyperoxia-based model of BPD in mice was conducted essentially as described previously, with the modifications outlined below (Alejandre-Alcázar et al., 2007 (link); Madurga et al., 2014 (link); Mižíková et al., 2015 (link)). Newborn C57Bl/6 mice (Mus musculus Linnaeus) were randomised to equal-sized litters (average seven mice per litter), and placed into either a normoxic or hyperoxic environment within two hours of birth. The hyperoxia-exposure protocols are illustrated in Fig. 1A,B. For the 40% O2, 60% O2, and 85% O2 oxygen exposure protocols, mouse pups were exposed to the appropriate oxygen concentration starting on the day of birth (P1), continuously up to and including P14. Two additional oxygen level protocols were also performed: (1) a decreasing gradient of O2 from 85% on P1 to 21% on P14 (a reduction in oxygen concentration of 5% per day); and (2) an oscillation between 85% O2 and 40% O2, for a 24 h period, on a 24 h:24 h oscillation cycle.
To determine the necessary window of oxygen exposure over the first 14 days of life, newborn mouse pups were exposed to 85% O2 for discrete ‘windows’, which included: (1) the first 24 h of life (P1), (2) the first three days of life, starting at P1, up to and including P3; (3) starting at the beginning of P4 and continuing to (and including) P7; (4) the first seven days of life, starting at P1, and continuing to (and including) P7; and (5) the entire first 14 days of life, ending with (and including) P14. All experiments were terminated at P14.
For all oxygen-exposure protocols, nursing dams were rotated every 24 h, to ensure at least one 24 h period of 21% O2 every 2 days. This addresses the oxygen toxicity issues in adult mice, which are highly susceptible to prolonged periods of hyperoxia. Nursing dams received food ad libitum. Mice were maintained in a 12 h:12 h dark/light cycle. All pups were euthanised at the end of P14 with an overdose of pentobarbital (500 mg/kg, intraperitoneal; Euthoadorm, CP-Pharma, Burgdorf, Germany), followed by thoracotomy, then by lung extraction and processing for design-based stereology (Madurga et al., 2014 (link); Mižíková et al., 2015 (link)).
Full text: Click here
Publication 2017
Adult Birth Drug Overdose Food Hyperoxia Hypoxia Infant, Newborn Lung Mice, House Mice, Inbred C57BL Oxygen Pentobarbital Thoracotomy
Categorical variables were compared using the chi-square test. Continuous variables were compared using student t-test or Wilcoxon rank-sum test, based on the distribution of the data. We used Spearman’s correlation coefficient (r) to assess the relationship between 1- and 6-hour PaO2, and the corresponding FiO2 and SaO2. We used multivariable logistic regression analysis to identify what patient and management characteristics were associated with hyperoxia (see Supplemental Methods).
For the primary outcome, we calculated relative risk (RR) using multivariable generalized linear regression with a log link33 (link) to test if exposure to hyperoxia during the initial six hours after ROSC was an independent predictor of poor neurologic function at hospital discharge. We a priori defined hyperoxia as PaO2 > 300 mmHg on one or more ABG analyses, based on previously described definition for hyperoxia.6 (link), 7 (link), 10 (link), 13 (link)A priori, we selected the following candidate variables for the regression model on the grounds that they were previously demonstrated to predict outcome in post–cardiac arrest patients: (1) age (decile); (2) initial cardiac rhythm [asystole or pulseless electrical activity (PEA) vs. ventricular fibrillation/pulseless ventricular tachycardia (VF/VT)];34 (link) (3) metabolic acidosis (defined as one or more recorded base deficit ≤ -6 during the initial six hours after ROSC, based on previously published literature);35 (link) (4) arterial hypotension (mean arterial pressure < 70 mmHg during the initial six hours after ROSC);21 (link) (5) pre-arrest comorbidities (i.e., Charlson comorbidities index);36 (link) (6) prolonged duration of CPR (CPR duration > 20 min);37 (link) and (7) location of cardiac arrest (in- vs. out-of-hospital).38 (link)–41 (link) Backward elimination with a criterion of p < 0.05 for retention in the model was used. Statistical interactions and collinearity were assessed. Goodness of fit of the model was evaluated with the deviance test. This analysis was repeated for both secondary outcomes. For the main analyses listwise deletion was used for missing co-variables. We also report results using multiple imputation for missing co-variables. These models used robust standard error and took into account the random effects at the institution (i.e. site of enrollment) level.
We performed several additional pre-planned sensitivity analyses for the primary outcome. First, we entered additional covariates beyond those pre-specified into a multivariable generalized linear regression model with a log link. Second, we assessed whether cardiac arrest location (pre-hospital or in-hospital) had different results. Finally, we performed a sensitivity analysis limited to only patients who survived to hospital discharge (detailed description of sensitivity analyses is discussed in Supplemental Methods).
We also examined the association between PaO2 and outcome across different thresholds to define hyperoxia (i.e. PaO2 > 100, 150, 200, 250, 300, 350, and 400 mmHg on one or more ABG analyses). We entered each threshold into a multivariable generalized linear regression model with a log link and calculated relative risks with 95% confidence intervals (CI) for poor neurological outcome adjusting for candidate variables retained in the original model. We graphed the relative risks with 95% CI and inspected the graph to assess if there was a threshold signal for neurological outcome over increasing PaO2 cut points.
To reflect the duration of hyperoxia exposure during the initial six hours after ROSC, we used the first PaO2 measurement to represent the PaO2 exposure during the time from ROSC to the first ABG measurement. We then calculated the time intervals between ABG measurements and inferred that the PaO2 remained constant at the level observed in the earlier measurement until the time point of the subsequent measurement (i.e. last value carried forward). Similar methodology to estimate PaO2 exposure has been used previously.16 (link) We then added up the total time patients had exposure to hyperoxia during the initial six hours after ROSC. To test the impact of duration of hyperoxia exposure, we entered duration of exposure as a continuous variable (calibrated for one hour) into a multivariable generalized linear regression model with a log link adjusting for the candidate variables retained in the original model. Given some subjects had ABG analyses ordered by treating physicians in addition to the protocol, we adjusted the model for the total number of ABG analyses obtained during the initial six hours after ROSC, as well as time to first ABG.
Publication 2018
Acidosis, Metabolic Cardiac Arrest Deletion Mutation Electricity Heart Hyperoxia Hypersensitivity Nervous System Physiological Phenomena Patient Discharge Patients Physicians Retention (Psychology) Student Tachycardia, Ventricular

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2013
Animals Childbirth Hyperoxia Lung Maternal Inheritance Patient Holding Stretchers Plexiglas

Most recents protocols related to «Hyperoxia»

Example 7

The following Example is an exemplary assay to evaluate VGX-300 and VGX-301-ΔN2 for their ability to inhibit the onset of retinal neovascularization using the ROP model. In this model, postnatal day 7 (P7) mice are exposed to hyperoxia (75% oxygen) for 5 days (to P12). After hyperoxic exposure, P12 mice are returned to normoxia, and administered an intravitreal injection of human isotype control antibody, VGX-300, VGX-301-ΔN2, Eylea (VEGF-Trap), VGX-300+Eylea or VGX-301-ΔN2+Eylea. All mice are then housed under normoxic conditions for 5 days before sacrifice at P17, enucleation and fixation in 10% formalin/PBS. Vessels will be quantified in each group using H&E and/or IHC staining methods.

Full text: Click here
Patent 2024
aflibercept Biological Assay Blood Vessel Cardiac Arrest eylea Formalin Homo sapiens Hyperoxia Immunoglobulin Isotypes Mus Oxygen Retinal Neovascularization Staining

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2023
Cells Hyperoxia Infant, Newborn Lung Mice, Inbred C57BL Oxygen Tissues
WT (NLRX1+/+) and NLRX1 knock-out (NLRX1−/−) mice were exposed to > 95% oxygen (Hyperoxia, HO) in cages enclosed in an airtight Plexiglas chamber (57 × 42 × 37 cm, JEUNG DO BIO & PLANT Co., Seoul, Korea). The chamber was maintained at atmospheric pressure. Oxygen levels were monitored for the duration of the experiment (72 h) using an oxygen analyzer (MaxO2+A, MAXTEC, Salt Lake City, UT). As controls, sex- and age-matched WT and NLRX1−/− mice were housed in similar conditions under normoxia (room air, RA). For the four experimental groups (WT RA, WT HO, NLRX1−/− RA, NLRX1−/− HO), each group consisted of 3–5 mice, and the experiment was performed at least 3 times.
Full text: Click here
Publication 2023
Atmospheric Pressure Hyperoxia Mice, House Oxygen Plants Plexiglas Sodium Chloride, Dietary
The same surgical procedures were performed as described above and rats were assigned into 2 groups at 10 min after CPR (Fig. 1C): (1) The post-resuscitation normoxic therapy group (n = 6) included those that were successfully resuscitated from 10-min asphyxia CA and treated with inhaled 30% oxygen (CA-Normo) following the initial 10 min of 100% oxygen, and (2) The post-resuscitation hyperoxia group (n = 6) included those treated with inhaled 100% oxygen (CA-Hypero) during the entire observational period. For all rats, the brain and heart tissues were collected at 2 h after CPR for mRNA extraction, followed by complementary DNA (cDNA) synthesis and real-time PCR. Additionally, tissues of control (naive) rats were collected to create a reference for mRNA gene expression.
RNA isolation, reverse transcription, and real-time PCR analysis for the brain, heart, and lung samples extracted at 2 h after CA were performed according to manufacturer instructions. Briefly, total RNAs were extracted and reverse transcribed using TRIzol Reagent® (Invitrogen, Carlsbad, CA) and SuperScript™ IV VILO™ Master Mix with ezDNase™ Enzyme (Invitrogen, Carlsbad, CA), respectively. Real-time PCR was performed using TaqMan™ Fast Advanced Master Mix (Applied Biosystems™, Waltham, MA) on the LightCycler 480 system (Roche Diagnostics, Mannheim, Germany). All primers were purchased from Thermofisher: Glyceraldehyde-3-phosphate dehydrogenase (Gapdh, TaqMan Assay ID: Rn01775763_g1), Interleukin-1 beta (Il1b, Rn00580432_m1), Interleukin-6 (Il6, Rn01410330_m1), Transforming growth factor-beta 1 (Tgfb1, Rn00572010_m1), Intercellular adhesion molecule-1 (Icam1, Rn00564227_m1), Nuclear factor-kappa beta 1 (Nfkb1, Rn01399583_m1), Tumor necrosis factor (Tnf) receptor-associated factor-6 (Traf6, Rn01512911_m1), Caspase-3 (Casp3, Rn00563902_m1), Caspase-9 (Casp9, Rn00581212_m1), Epidermal growth factor (Egf, Rn00563336_m1), and B-cell leukemia/lymphoma-2 (Bcl2) associated X protein (Bax, Rn02532082_g1).
Full text: Click here
Publication 2023
Anabolism Asphyxia B-Cell Lymphomas Bax Protein Biological Assay Brain CASP9 protein, human Caspase 3 Caspase 9 Diagnosis DNA, Complementary Enzymes Epidermal growth factor GAPDH protein, human Genes, vif Glyceraldehyde-3-Phosphate Dehydrogenases Heart Hyperoxia Intercellular Adhesion Molecule-1 Interleukin-1 Interleukin-1 beta isolation Leukemia Leukemia, B-Cell Lung Lymphoma NF-kappa B Oligonucleotide Primers Operative Surgical Procedures Oxygen Rattus norvegicus Real-Time Polymerase Chain Reaction Resuscitation Reverse Transcription RNA RNA, Messenger TGF-beta1 TGFB1 protein, human Therapeutics Tissues TNF Receptor Associated Factor 6 Transcription, Genetic trizol
The hypoxic gas mixture for the trials was created by the Biomedtech GO2Altitude ERA II Hypoxic/Hyperoxic Air Generator (Australia). The manufacturer’s recommendations were followed in order to reduce the oxygen concentration of the inspiratory gas mixture to replicate height above sea level (a.s.l.), as stated in the GO2Altitude ERA II Hypoxicator System Operational Manual (Biomedtech Australia Pty Ltd., Biomedical Research and Development). The FIO2 = 13% oxygen level in the mixture was utilized to construct a hypoxic mix that accurately reflected altitude at 3500 m a.s.l.. Participants were not aware of the gas mixture but were breathing normally. They also wore pulse oximeters and donned masks when doing testing in normoxia, even though the air generator at the time only delivered a sea level breathing mixture [33 (link)].
Full text: Click here
Publication 2023
Hyperoxia Hypoxia Inhalation nitrox Oxygen Oxygen-13 Pulse Rate

Top products related to «Hyperoxia»

Sourced in United States, China, United Kingdom, Germany, Australia, Japan, Canada, Italy, France, Switzerland, New Zealand, Brazil, Belgium, India, Spain, Israel, Austria, Poland, Ireland, Sweden, Macao, Netherlands, Denmark, Cameroon, Singapore, Portugal, Argentina, Holy See (Vatican City State), Morocco, Uruguay, Mexico, Thailand, Sao Tome and Principe, Hungary, Panama, Hong Kong, Norway, United Arab Emirates, Czechia, Russian Federation, Chile, Moldova, Republic of, Gabon, Palestine, State of, Saudi Arabia, Senegal
Fetal Bovine Serum (FBS) is a cell culture supplement derived from the blood of bovine fetuses. FBS provides a source of proteins, growth factors, and other components that support the growth and maintenance of various cell types in in vitro cell culture applications.
Sourced in United States
The OxyCycler is a versatile lab equipment used for monitoring and controlling oxygen levels in various applications. It provides precise measurement and regulation of oxygen concentration within a defined environment.
Sourced in United States, Montenegro, Japan, Canada, United Kingdom, Germany, Macao, Switzerland, China
C57BL/6J mice are a widely used inbred mouse strain. They are a commonly used model organism in biomedical research.
Sourced in United States, United Kingdom, Germany, China, France, Canada, Japan, Australia, Switzerland, Italy, Israel, Belgium, Austria, Spain, Brazil, Netherlands, Gabon, Denmark, Poland, Ireland, New Zealand, Sweden, Argentina, India, Macao, Uruguay, Portugal, Holy See (Vatican City State), Czechia, Singapore, Panama, Thailand, Moldova, Republic of, Finland, Morocco
Penicillin is a type of antibiotic used in laboratory settings. It is a broad-spectrum antimicrobial agent effective against a variety of bacteria. Penicillin functions by disrupting the bacterial cell wall, leading to cell death.
Sourced in United States, United Kingdom, Germany, China, France, Canada, Australia, Japan, Switzerland, Italy, Belgium, Israel, Austria, Spain, Netherlands, Poland, Brazil, Denmark, Argentina, Sweden, New Zealand, Ireland, India, Gabon, Macao, Portugal, Czechia, Singapore, Norway, Thailand, Uruguay, Moldova, Republic of, Finland, Panama
Streptomycin is a broad-spectrum antibiotic used in laboratory settings. It functions as a protein synthesis inhibitor, targeting the 30S subunit of bacterial ribosomes, which plays a crucial role in the translation of genetic information into proteins. Streptomycin is commonly used in microbiological research and applications that require selective inhibition of bacterial growth.
Sourced in United States
The Plexiglas chamber is a clear, rigid enclosure made of acrylic material. It is designed to provide a controlled, contained environment for various applications. The chamber's primary function is to create a designated space with regulated conditions, such as temperature, humidity, or atmospheric composition, as required by the user's specific needs.
Sourced in United States
The ProOx Model 110 is a laboratory instrument designed to control and monitor the oxygen levels within a controlled environment. It provides precise control and monitoring of oxygen concentrations.
Sourced in United States, United Kingdom, Germany, France
The ROS-Glo™ H2O2 Assay is a luminescent assay designed to detect and quantify hydrogen peroxide (H2O2) in biological samples.
Sourced in China, United States, Germany, United Kingdom, Canada, Japan, France, Italy, Morocco, Spain, Netherlands, Montenegro, Belgium, Portugal, Ireland, Hungary
The C57BL/6 mouse is a widely used inbred mouse strain. It is a common laboratory mouse model utilized for a variety of research applications.

More about "Hyperoxia"

Hyperoxia, also known as oxygen toxicity or oxygen poisoning, refers to an abnormally high concentration of oxygen in the body's tissues.
This condition can occur during supplemental oxygen therapy or in certain medical conditions.
Hyperoxia has been extensively studied for its potential therapeutic applications, particularly in the context of conditions such as stroke, traumatic brain injury, and other ischemic disorders.
Optimizing hyperoxia protocols can be challenging, as the effects can vary depending on factors like duration, oxygen concentration, and method of delivery.
PubCompare.ai helps users locate protocols from literarature, pre-prints, and patents while using AI-driven comparisons to identify the best protocols and products for reproducible, evidence-based hyperoxia research.
Researchers often utilize animal models like C57BL/6J mice to study the effects of hyperoxia.
Exposing these mice to hyperoxic conditions in a Plexiglas chamber can provide insights into the underlying mechanisms and potential therapeutic interventions.
Monitoring parameters like reactive oxygen species (ROS) levels using assays like the ROS-Glo™ H2O2 Assay can help evaluate the impact of hyperoxia on cellular processes.
In addition to animal studies, in vitro experiments using cell lines and tissues can also contribute to our understanding of hyperoxia.
Culturing cells under hyperoxic conditions, while monitoring cell viability and proliferation, can shed light on the direct effects of oxygen toxicity.
Incorporating antibiotics like Penicillin and Streptomycin can help maintain sterile cell culture conditions during these experiments.
Ultimately, the insights gained from hyperoxia research, facilitated by tools like PubCompare.ai, can lead to the development of optimized protocols and therapeutic strategies for various ischemic and oxidative stress-related disorders.
By leveraging AI-driven protocol comparisons and a range of experimental models, researchers can advance our understanding of hyperoxia and its clinical implications.